Medical use of cannabis. Cannabidiol: a new light for schizophrenia?
Subject: Schizophrenia - PUBLISHED VIA Drug Testing and Analysis
Author(s):
Deiana S
View Source >>
(Price: $38)
Related Studies:
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia.
Published via Translational Psychiatry
Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug.
Published via Brazilian Journal of Medical and Biological Research
Cannabidiol as a potential treatment for psychosis.
Published via European Neuropsychopharmacology
A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation.
Published via Current Pharmaceutical Design
Peripheral endocannabinoid system dysregulation in first-episode psychosis.
Published via Neuropsychopharmacology